Is Your Child's Allowance Undermining Your Retirement?
The $1,000 Challenge, Part 9: Nibbling Away at the Family Food Bills
The Benefits of Filing Your Taxes Early
After Market: Teen Retailers' Moody News Sets Downbeat Tone for Stocks
Prem Watsa Cuts One of His 'Most Successful Investments'
Bearish Canadian Investor Prem Watsa's 7 New Positions
ViroPharma Announces Results of Tender Offer for its 2.00% Convertible Senior Notes Due 2017
Shire's CEO Discusses Q4 2013 Results - Earnings Call Transcript
Shire Delivers Double Digit Product Sales Growth and 23% Increase in Non GAAP Earnings per ADS
Bidding adieu to Exton's ViroPharma
Mario Gabelli's Top 5 Fourth-Quarter Stock Buys
$4.2 Billion Deal Gives ViroPharma Incorporated Execs Huge Paydays
Shire purchase of ViroPharma generates big payday for executives, board members